Inventor · disambiguated record
Jason M. Perry
Also filed as: PERRY JASON M
19 granted patents·16 pending applications·128 citations·filing 2012–2025
94Inventor score
Files withALKERMES PHARMA IRELAND LTD22PULMATRIX OPERATING CO INC10CIPLA TECH LLC1PERRY JASON M1PULMATRIX INC1
Top patents by PatentIndex Score
35 records- 0197US9351976B2Pharmaceutical compositions comprising sorbitan estersALKERMES PHARMA IRELAND LTD·Filed 2015·Granted May 31, 2016·22 cites·20 claims
- 0295US11969469B2Pharmaceutical compositions having improved storage stabilityALKERMES PHARMA IRELAND LTD·Filed 2021·Granted Apr 30, 2024·2 cites·8 claims
- 0393US9193685B2Pharmaceutical compositions having improved storage stabilityALKERMES PHARMA IRELAND LTD·Filed 2013·Granted Nov 24, 2015·17 cites·14 claims
- 0492US9861699B2Pharmaceutical compositions having improved storage stabilityALKERMES PHARMA IRELAND LTD·Filed 2015·Granted Jan 9, 2018·8 cites·12 claims
- 0591US11097006B2Pharmaceutical compositions having improved storage stabilityALKERMES PHARMA IRELAND LTD·Filed 2020·Granted Aug 24, 2021·2 cites·15 claims
- 0691US10064859B2Crystallization process of aripiprazole derivatives in extended release formulations for treatment of schizophreniaALKERMES PHARMA IRELAND LTD·Filed 2015·Granted Sep 4, 2018·10 cites·18 claims
- 0791US9034867B2Pharmaceutical compositions comprising sorbitan estersPERRY JASON M·Filed 2012·Granted May 19, 2015·27 cites·29 claims
- 0890US10973816B2Crystallization process of aripiprazole derivatives in extended release formulations for treatment of schizophreniaALKERMES PHARMA IRELAND LTD·Filed 2019·Granted Apr 13, 2021·3 cites·24 claims
- 0989US12311027B2Pharmaceutical compositions having improved storage stabilityALKERMES PHARMA IRELAND LTD·Filed 2024·Granted May 27, 2025·0 cites·15 claims
- 1088US11883394B2Crystallization process of aripiprazole derivatives in extended release formulations for treatment of schizophreniaALKERMES PHARMA IRELAND LTD·Filed 2021·Granted Jan 30, 2024·1 cites·20 claims
- 1188US9999670B2Pharmaceutical compositions comprising benzyl alcoholALKERMES PHARMA IRELAND LTD·Filed 2013·Granted Jun 19, 2018·11 cites·12 claims
- 1287US2024131024A1Pharmaceutical compositions comprising sorbitan estersALKERMES PHARMA IRELAND LTD·Filed 2023·Application pending·0 cites
- 1386US10478434B2Crystallization process of aripiprazole derivatives in extended release formulations for treatment of schizophreniaALKERMES PHARMA IRELAND LTD·Filed 2018·Granted Nov 19, 2019·4 cites·23 claims
- 1485US9993556B2Pharmaceutical compositions comprising fatty glycerol estersALKERMES PHARMA IRELAND LTD·Filed 2013·Granted Jun 12, 2018·8 cites·13 claims
- 1585US2024058327A1Pharmaceutical Compositions Comprising Sorbitan EstersALKERMES PHARMA IRELAND LTD·Filed 2023·Application pending·0 cites
- 1684US10226458B2Pharmaceutical compositions comprising sorbitan estersALKERMES PHARMA IRELAND LTD·Filed 2016·Granted Mar 12, 2019·1 cites·21 claims
- 1784US2024245676A1Crystallization process of aripiprazole derivatives in extended release formulations for treatment of schizophreniaALKERMES PHARMA IRELAND LTD·Filed 2023·Application pending·0 cites
- 1883US10342877B2Pharmaceutical compositions having improved storage stabilityALKERMES PHARMA IRELAND LTD·Filed 2017·Granted Jul 9, 2019·2 cites·23 claims
- 1982US2025312459A1Pharmaceutical Compositions Having Improved Storage StabilityALKERMES PHARMA IRELAND LTD·Filed 2025·Application pending·0 cites
- 2081US10004807B2Pharmaceutical compositions comprising fatty acid estersALKERMES PHARMA IRELAND LTD·Filed 2013·Granted Jun 26, 2018·5 cites·16 claims
- 2180US9737518B2Tiotropium dry powdersPULMATRIX INC·Filed 2015·Granted Aug 22, 2017·5 cites·23 claims
- 2277US10639376B2Pharmaceutical compositions having improved storage stabilityALKERMES PHARMA IRELAND LTD·Filed 2019·Granted May 5, 2020·0 cites·19 claims
- 2374US2019216805A1Pharmaceutical Compositions Comprising Sorbitan EstersALKERMES PHARMA IRELAND LTD·Filed 2019·Application pending·0 cites
- 2471US2024285523A1Antifungal dry powdersPULMATRIX OPERATING CO INC·Filed 2023·Application pending·0 cites
- 2561US2025221928A1Antifungal dry powdersPULMATRIX OPERATING CO INC·Filed 2025·Application pending·0 cites
- 2661US2025049717A1Dry powder formulations of narrow spectrum kinase inhibitorsPULMATRIX OPERATING CO INC·Filed 2022·Application pending·0 cites
- 2758US2024033218A1Dihydroergotamine dry powder formulations and methods of usePULMATRIX OPERATING CO INC·Filed 2022·Application pending·0 cites
- 2857US2016038508A1Pharmaceutical compositions comprising sorbitan estersALKERMES PHARMA IRELAND LTD·Filed 2015·Application pending·0 cites
- 2950US11116722B2Antifungal dry powdersPULMATRIX OPERATING CO INC·Filed 2017·Granted Sep 14, 2021·0 cites·25 claims
- 3046US2019167579A1Itraconazole dry powdersPULMATRIX OPERATING CO INC·Filed 2018·Application pending·0 cites
- 3142US2017312258A1Tiotropium dry powdersPULMATRIX OPERATING CO INC·Filed 2017·Application pending·0 cites
- 3241US2017304198A1Improved stability of dry powders containing tiotropium and amino acidPULMATRIX OPERATING CO INC·Filed 2015·Application pending·0 cites
- 3338US2021113461A1Methods of Treating Fungal InfectionsCIPLA TECH LLC·Filed 2019·Application pending·0 cites
- 3438US2021145739A1Antifungal formulations for pulmonary administration comprising itraconazolePULMATRIX OPERATING CO INC·Filed 2019·Application pending·0 cites
- 3535US2017304197A1Formulations containing tiotropium, amino acid and acid and methods thereofPULMATRIX OPERATING CO INC·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jason M. Perry files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →